Are Comorbidities in Patients with Chronic Inflammatory Rheumatic Diseases Associated with Treatment Adherence to Biosimilars in a Non-medical Switch Scenario?

被引：0
|
作者：
Redeker, Imke [1 ]
Moustakis, Stefan [2 ]
Tsiami, Styliani [2 ]
Baraliakos, Xenofon [2 ]
Andreica, Ioana [2 ]
Buehring, Bjoern [2 ]
Braun, Juergen [2 ]
Kiltz, Uta [2 ]
机构：
[1] German Rheumatism Res Ctr DRFZ, Berlin, Germany
[2] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Herne, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0235
引用
收藏
页码：468 / 472
页数：5
相关论文
共 50 条
  • [1] ARE COMORBIDITIES IN PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TREATMENT NON-ADHERENCE TO BIOSIMILARS IN A NON-MEDICAL SWITCH SCENARIO?
    Redeker, I.
    Moustakis, S.
    Tsiami, S.
    Baraliakos, X.
    Andreica, I.
    Buehring, B.
    Braun, J.
    Kiltz, U.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1805 - 1806
  • [2] A Bayesian model to analyse the association of comorbidities with biosimilar treatment retention in a non-medical switch scenario in patients with inflammatory rheumatic musculoskeletal diseases
    Redeker, Imke
    Moustakis, Stefan
    Tsiami, Styliani
    Baraliakos, Xenofon
    Kiefer, David
    Andreica, Ioana
    Buehring, Bjoern
    Braun, Juergen
    Kiltz, Uta
    ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [3] The Psychological Risks Associated With the Non-medical Switch From Biologics to Biosimilars
    Mazzoni, Davide
    Vener, Claudia
    Mazzocco, Ketti
    Monzani, Dario
    Pravettoni, Gabriella
    FRONTIERS IN PSYCHOLOGY, 2021, 12
  • [4] MEDICAL-TREATMENT OF CHRONIC INFLAMMATORY RHEUMATIC DISEASES
    KAHN, MF
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1975, 5 : 97 - 104
  • [5] Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients - a multicentre study on efficacy and drug sustainability
    Lontai, L.
    Gonczi, L.
    Balogh, F.
    Komlodi, N.
    Resal, T.
    Farkas, K.
    Molnar, T.
    Golovics, P.
    Schafer, E.
    Szamosi, T.
    Miheller, P.
    Ilias, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I518 - I519
  • [6] NON-MEDICAL SWITCH BETWEEN ADALIMUMAB BIOSIMILARS AND FROM THE ORIGINATOR ADALIMUMAB TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS - A MULTICENTRE STUDY ON EFFICACY AND DRUG SUSTAINABILITY
    Lontai, Livia
    Gonczi, Lorant
    Balogh, Fruzsina
    Komlodi, Nora
    Resal, Tamas
    Farkas, Klaudia
    Molnar, Tamas
    Miheller, Pal
    Golovics, Petra A.
    Schafer, Eszter
    Szamosi, Tamas
    Ilias, Akos
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2022, 162 (07) : S606 - S606
  • [7] Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients - a multicentre study on efficacy and drug sustainability
    Lontai, L.
    Gonczi, L.
    Balogh, F.
    Komlodi, N.
    Resal, T.
    Farkas, K.
    Molnar, T.
    Golovics, P.
    Schafer, E.
    Szamosi, T.
    Miheller, P.
    Ilias, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I518 - I519
  • [8] MEDICAL-TREATMENT OF CHRONIC INFLAMMATORY RHEUMATIC DISEASES IN ADULTS
    KAHN, MF
    SCHWEIZERISCHE RUNDSCHAU FUR MEDIZIN PRAXIS, 1977, 66 (44): : 1402 - 1411
  • [9] FACTORS ASSOCIATED WITH ADHERENCE TO OSTEOPOROSIS TREATMENT IN PATIENTS WITH RHEUMATIC DISEASES
    Nikitinskaya, Oxana
    Toroptsova, Natalia
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1895 - 1895
  • [10] Factors associated with adherence to treatment in children and adolescents with chronic rheumatic diseases
    Bugni, Vanessa M.
    Ozaki, Luciana S.
    Okamoto, Karine Y. K.
    Barbosa, Cassia M. P. L.
    Hilario, Maria Odete E.
    Len, Claudio A.
    Terreri, Maria Teresa
    JORNAL DE PEDIATRIA, 2012, 88 (06) : 483 - 488
12345